Kenneth Kashkin

Kenneth Kashkin

Direktor/Vorstandsmitglied bei EVOME MEDICAL TECHNOLOGIES INC.
75 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Kenneth B. Kashkin is the founder of K2 Biotechnology Ventures LLC, founded in 2017.
Dr. Kashkin is currently serving as Vice Chairman at Evome Medical Technologies, Inc. since 2020.
Former positions include President & CEO-Institute Research & Innovation at CommonSpirit Health from 2011 to 2014, Director at Abbott Laboratories in 1997, Associate Director-Central Nervous System at Bayer AG, Medical Director at Nova Pharmaceutical Corp., Vice President at Baxter Healthcare Corp.
from 2008 to 2011, Chief Medical Officer & Executive Vice President at Genaissance Pharmaceuticals, Inc., Chief Medical Officer & VP-Clinical Research at Ferring Pharmaceuticals, Vice President-Clinical Development at Knoll Pharmaceutical Co. in 2000, and Chief Operating Officer & Head-Therapeutics at Chromocell Corp.
from 2014 to 2020.
Education includes undergraduate and doctorate degrees from the University of California, Los Angeles.

Aktive Positionen von Kenneth Kashkin

UnternehmenPositionBeginn
EVOME MEDICAL TECHNOLOGIES INC. Direktor/Vorstandsmitglied 17.03.2025

Ehemalige bekannte Positionen von Kenneth Kashkin

UnternehmenPositionEnde
Geschäftsführer 01.01.2020
Corporate Officer/Principal 01.01.2014
Corporate Officer/Principal 01.01.2011
Knoll Pharmaceutical Co.
Corporate Officer/Principal 01.01.2000
ABBOTT LABORATORIES Direktor/Vorstandsmitglied 01.01.1997
Sehen Sie sich die Erfahrung von Kenneth Kashkin im Detail an

Ausbildung von Kenneth Kashkin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

76

Beziehungen ersten Grades

15

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen15

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

Knoll Pharmaceutical Co.

Nova Pharmaceutical Corp.

Commercial Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

  1. Börse
  2. Insiders
  3. Kenneth Kashkin